scholarly journals Validation of the Distress Thermometer, Impact Thermometer and combinations of these in screening for distress

2011 ◽  
Vol 20 (6) ◽  
pp. 609-614 ◽  
Author(s):  
Donald McLaren Baken ◽  
Cheryl Woolley

BMC Cancer ◽  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Fangkun Liu ◽  
Jing Huang ◽  
Liyang Zhang ◽  
Fan Fan ◽  
Jindong Chen ◽  
...  






Author(s):  
Emma Harbeck ◽  
Suzanne Chambers ◽  
Janine Porter‐Steele ◽  
Debra Anderson ◽  
Jasotha Sanmugarajah ◽  
...  


2013 ◽  
Vol 04 (01) ◽  
pp. 18-23
Author(s):  
D. Wiewrodt

ZusammenfassungPsychoonkologische Interventionen bei Patienten mit Hirntumoren verbessern die Lebensqualität, fördern die Compliance, stärken die Ressourcen des Betroffenen und seiner Familie und können Folgestörungen vermeiden. Trotzdem ist ein psychoonkologisches Screening bei Hirntumor-Patienten nur selten etabliert. Je nach Screening-Instrument ist in der akuten stationären Phase mit etwa 20 bis 50% und in der Nachsorge mit etwa einem Drittel überschwellig belasteter Patienten zu rechnen. Da objektive medizinische oder soziodemografische Daten wie Tumorgrad, Tumorlokalisation, Geschlecht oder Alter nicht sicher mit den psychosozialen Belastungen korrelieren und die Fremdeinschätzung belastete Patienten nur unzureichend erfasst, ist ein Screening aller Hirntumor-Patienten unerlässlich. Die von der Deutschen Krebsgesellschaft empfohlenen Screening-Instrumente sind anwendbar; für Hirntumor-Patienten gesondert validiert wurde das Distress-Thermometer. Werden bestimmte Schwellenwerte überschritten, sollte eine individuelle und bedarfsgerechte psychoonkologische Intervention erfolgen, die in Abhängigkeit der Symptomatik von der entsprechenden Berufsgruppe erbracht wird.



2020 ◽  
Vol 18 (6) ◽  
pp. 648-657
Author(s):  
Karen E. Steinhauser ◽  
Karen M. Stechuchak ◽  
Katherine Ramos ◽  
Joseph Winger ◽  
James A. Tulsky ◽  
...  

AbstractObjectiveCompare the efficacy of two interventions addressing emotional and existential well-being in early life-limiting illness.MethodPrimary trial analysis (n = 135) included patients with advanced cancer, congestive heart failure, or end-stage renal disease; Arm 1 received the Outlook intervention, addressing issues of life completion and preparation, and Arm 2 received relaxation meditation (RM). Primary outcomes at five weeks (primary endpoint) and seven weeks (secondary): completion and preparation (QUAL-E); secondary outcomes: anxiety (POMS) quality of life (FACT-G) and spiritual well-being (FACIT-Sp) subscales of faith, meaning, and peace.ResultsAverage age was 62; 56% were post-high school-educated, 54% were married, 52% white, 44% female, and 70% had a cancer diagnosis. At baseline, participants demonstrated low levels of anxiety (<5 on POMS subscale) and depression (<10 on CESD) relative to population norms. Results of the primary analysis revealed no significant differences in mean Preparation by treatment arm at five weeks (14.4 Outlook vs. 14.8 RM; between-group difference −0.4 [95% CI, −1.6, 0.8], p = 0.49) or seven weeks (15.2 vs.15.4; between-group difference −0.2 [95% CI, −1.5, 1.0], p = 0.73). There were also no significant differences in mean Life Completion by treatment arm between five weeks (26.6 Outlook vs. 26.3 RM; between-group difference 0.2 [95% CI, −1.2, 1.7], p = 0.76) or seven weeks (26.5 vs. 27.5; between-group difference −1.0 [95% CI, −2.7, 0.7], p = 0.23). Compared to RM, Outlook participants did not have significant differences over time in the secondary outcomes of overall quality of life, anxiety, depression, FACT-G subscales, and FACIT-Sp subscales.DiscussionIn early-stage life-limiting illness, Outlook did not demonstrate a significant difference in primary or secondary outcomes relative to RM. Results underscore the importance of pre-screening for distress. Qualitatively, Outlook participants were able to express suppressed emotions, place illness context, reflect on adaptations, and strengthen identity. Screening for distress and identifying specified measures of distress, beyond anxiety and depression, is essential in our ability to adequately assess the multi-dimensional mechanisms that decrease existential suffering.





Author(s):  
Michael Hollifield ◽  
Eric C. Toolson ◽  
Sasha Verbillis-Kolp ◽  
Beth Farmer ◽  
Junko Yamazaki ◽  
...  

There is little work published about predictors of specific trajectory types of distress in refugees of war during early resettlement in a host country. Data about distress (Refugee Health Screener—15 (RHS-15)) and possible predictors of distress were collected at the domestic medical examination (T1) within 90 days of arrival and the civil surgeon examination (T2) 11–16 months after T1 for refugee groups from three countries (COU). Descriptive, correlative, analyses of variance, and regression techniques were used to determine trajectory type and their predictors. A higher percentage (7.3%) were distressed at T2 than at T1. By group, the Bhutanese became more distressed, the Burmese became less distressed, and Iraqi’s continued to have high distress. A regression model showed gender, loss, post-migration stress, and self-efficacy to be significant predictors of trajectory type (R2 = 0.46). When the T1 RHS-15 score was added to the model, observed variance increased (R2 = 0.53) and T1 RHS score accounted for the majority of variance (r = 0.64, p < 0.001), with post-migration stress accounting for markedly less (β = 0.19, p = 0.03). Loss and self-efficacy became less significant. Loss was, however, a strong predictor of delayed and chronic distress trajectory type. These data suggest that screening for distress should occur at least twice during resettlement to detect those with initial distress and those with delayed distress. Screening should be coupled with identifying other social determinants of health and a comprehensive assessment to determine the need for intervention for secondary prevention (i.e., reducing delayed distress) and treatment (reducing chronic distress).



2009 ◽  
Vol 17 (2) ◽  
pp. 61-68 ◽  
Author(s):  
Alistair Campbell ◽  
Suzanne K. Steginga ◽  
Megan Ferguson ◽  
Alison Beeden ◽  
Melissa Walls ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document